BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

956 related articles for article (PubMed ID: 26045258)

  • 1. YAP and TAZ: a nexus for Hippo signaling and beyond.
    Hansen CG; Moroishi T; Guan KL
    Trends Cell Biol; 2015 Sep; 25(9):499-513. PubMed ID: 26045258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The world according to YAP: a continuous cross-talk between Wnt and Hippo pathways].
    Gilgenkrantz H
    Med Sci (Paris); 2013 Oct; 29(10):868-74. PubMed ID: 24148125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
    Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB
    Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hippo Pathway in Prostate Cancer.
    Salem O; Hansen CG
    Cells; 2019 Apr; 8(4):. PubMed ID: 31018586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between Hippo and TGFβ: Subcellular Localization of YAP/TAZ/Smad Complexes.
    Grannas K; Arngården L; Lönn P; Mazurkiewicz M; Blokzijl A; Zieba A; Söderberg O
    J Mol Biol; 2015 Oct; 427(21):3407-15. PubMed ID: 25937570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen regulates Hippo signaling via GPER in breast cancer.
    Zhou X; Wang S; Wang Z; Feng X; Liu P; Lv XB; Li F; Yu FX; Sun Y; Yuan H; Zhu H; Xiong Y; Lei QY; Guan KL
    J Clin Invest; 2015 May; 125(5):2123-35. PubMed ID: 25893606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifaceted regulation and functions of YAP/TAZ in tumors (Review).
    Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y
    Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yes-Associated Protein and PDZ Binding Motif: A Critical Signaling Pathway in the Control of Human Pluripotent Stem Cells Self-Renewal and Differentiation.
    Shi J; Farzaneh M; Khoshnam SE
    Cell Reprogram; 2020 Apr; 22(2):55-61. PubMed ID: 32125897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.
    Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL
    J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between YAP/TAZ and Metabolism.
    Koo JH; Guan KL
    Cell Metab; 2018 Aug; 28(2):196-206. PubMed ID: 30089241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hippo Signaling Pathway in Pancreatic Cancer.
    Ansari D; Ohlsson H; Althini C; Bauden M; Zhou Q; Hu D; Andersson R
    Anticancer Res; 2019 Jul; 39(7):3317-3321. PubMed ID: 31262852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP and TAZ, the conductors that orchestrate eye development, homeostasis, and disease.
    Zhu JY; Lin S; Ye J
    J Cell Physiol; 2018 Jan; 234(1):246-258. PubMed ID: 30094836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of the mammalian Hippo signaling pathway.
    Ji XY; Zhong G; Zhao B
    Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP/TAZ Are Mechanoregulators of TGF-
    Szeto SG; Narimatsu M; Lu M; He X; Sidiqi AM; Tolosa MF; Chan L; De Freitas K; Bialik JF; Majumder S; Boo S; Hinz B; Dan Q; Advani A; John R; Wrana JL; Kapus A; Yuen DA
    J Am Soc Nephrol; 2016 Oct; 27(10):3117-3128. PubMed ID: 26961347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lats1/2 Regulate Yap/Taz to Control Nephron Progenitor Epithelialization and Inhibit Myofibroblast Formation.
    McNeill H; Reginensi A
    J Am Soc Nephrol; 2017 Mar; 28(3):852-861. PubMed ID: 27647853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Crosstalk Between Hippo-YAP Pathway and Innate Immunity.
    Wang S; Zhou L; Ling L; Meng X; Chu F; Zhang S; Zhou F
    Front Immunol; 2020; 11():323. PubMed ID: 32174922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
    Crawford JJ; Bronner SM; Zbieg JR
    Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
    [No Abstract]   [Full Text] [Related]  

  • 20. The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies.
    Werneburg N; Gores GJ; Smoot RL
    Gene Expr; 2020 Jun; 20(1):67-74. PubMed ID: 31253203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.